Filing Flows

Filing Flows › Johnson & Johnson (JNJ) › Recalls, complaints & regulation

Johnson & Johnson (JNJ): recalls, EPA violations and clinical trials

Johnson & Johnson (JNJ) beyond its filings: 1 recall in the last 12 months (22 in five years, 0 Class I); 4 EPA-regulated facilities in violation, $101K in penalties over five years; 234 active clinical trials.

Latest recalls

EPA facilities in violation

Facility (as registered)CityStatusPenalties
JANSSEN PHARMACEUTICALS INC.Athens, GASignificant Violation$91K
JANSSEN PHARMACEUTICALS COMPANIES OF J&JTitusville, NJViolation Identified$4K
JOHNSON & JOHNSON CONSUMER PRODUCTS INCSkillman, NJViolation Identified—
JOHNSON & JOHNSON AVIATION DEPWest Trenton, NJViolation Identified—

Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.

Johnson & Johnson's latest quarter

Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.

Questions

Has Johnson & Johnson had any recalls?

22 recalls on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.

Has Johnson & Johnson been fined by the EPA?

The 105 EPA-regulated facilities on file under its name drew $101K in penalties over five years; 4 are in violation now.

How many clinical trials does Johnson & Johnson have?

234 active studies on ClinicalTrials.gov, 80 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.